The document examines the role of Terlipressin in treating refractory septic shock. It discusses how Terlipressin, a vasopressin analogue, has been used to treat conditions like variceal bleeding and hepatorenal syndrome. Some studies have found Terlipressin effective for septic shock resistant to norepinephrine. However, the evidence is limited and more large randomized controlled trials are needed before recommending regular use of Terlipressin for septic shock.